Cel­gene vet Jack­ie Fouse grabs the reins of a Vivek Ra­maswamy vant-up

Jack­ie Fouse has land­ed.

A lit­tle more than four months af­ter Fouse said she was “re­tir­ing” as pres­i­dent of Cel­gene, she’s back run­ning her own biotech as ex­ec­u­tive chair­man of Der­ma­vant, one of sev­er­al new “vants” that Roivant chief Vivek Ra­maswamy has kicked in­to play over the last three years.

Fouse wrapped up her fi­nal lap at Cel­gene a few days ago, end­ing a 3-month leg as a com­pa­ny ad­vis­er to see out her tran­si­tion from the big biotech, which has per­haps the busiest deal­mak­ing group in the in­dus­try.  She moves from a top job at a bell­wether com­pa­ny to a start­up with a few ad­vanced ther­a­pies in the clin­ic. And she tells me that the part­ner­ing work she did at Cel­gene will help her get start­ed on her new job as ex­ec­u­tive chair­man.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.